Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2017-06-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
国浩律师（深圳）事务所关于公司申请首次公开发行股票并在创业板上市之补充法律意见书（二）
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding Shenzhen BGI Genomics Co., Ltd.'s application for initial public offering (IPO) and listing on the ChiNext board. It includes extensive legal and regulatory compliance checks, shareholder and capital structure details, business scope, and audit report references. The document is not a financial report, earnings release, or management discussion but a legal opinion related to the IPO process. It is not a brief announcement or a certification letter but a substantive legal opinion document. This type of document fits best under the category of Regulatory Filings (RNS) as it is a regulatory compliance and legal opinion filing related to the IPO process, not a financial report or other specific category.
2017-06-26 Chinese
国浩律师（深圳）事务所关于公司申请首次公开发行股票并在创业板上市之律师工作报告
Audit Report / Information Classification · 95% confidence The document is a detailed legal work report by a law firm (国浩律师（深圳）事务所) regarding Shenzhen BGI Genomics Co., Ltd.'s application for an initial public offering (IPO) and listing on the ChiNext board of the Shenzhen Stock Exchange. It includes extensive legal due diligence, approvals, authorizations, shareholder meeting resolutions, and compliance with Chinese securities laws and regulations. The document references various legal opinions, audit reports, and regulatory filings related to the IPO process. It is not a financial report, earnings release, or a simple announcement but a comprehensive legal report supporting the IPO. This fits the category of an Audit Report / Information (AR) as it is a standalone legal audit report related to the IPO process, not the full annual report or a regulatory announcement. The document length (15,000 characters) and content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is AR with high confidence. H1 2015
2017-06-26 Chinese
公司章程（草案）
Regulatory Filings
2017-06-26 Chinese
首次公开发行股票并在创业板上市提示公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the initial public offering (IPO) of Shenzhen BGI Genomics Co., Ltd., including information about the stock issuance, subscription process, pricing, and underwriting. It references regulatory approval from the China Securities Regulatory Commission and provides procedural details for investors. The document does not contain financial statements or performance data, nor is it a report or transcript. It is an announcement related to capital raising and stock issuance activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 2131 characters, which is consistent with an announcement rather than a full report.
2017-06-26 Chinese
国浩律师（深圳）事务所关于公司申请首次公开发行股票并在创业板上市之补充法律意见书（五）
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding Shenzhen BGI Genomics Co., Ltd.'s application for initial public offering (IPO) and listing on the ChiNext board. It is titled as a "Supplementary Legal Opinion (Five)" and references previous legal opinions and reports related to the IPO process. The content includes extensive analysis of the company's independence, restructuring, financial data, and related party transactions, which are typical components of legal opinions supporting IPO filings. There is no indication that this is an annual report, earnings release, or other financial report. It is not a simple announcement or certification but a substantive legal document. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2017-06-26 Chinese
国浩律师（深圳）事务所关于公司申请首次公开发行股票并在创业板上市之补充法律意见书（三）
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding Shenzhen BGI Genomics Co., Ltd.'s application for an initial public offering (IPO) and listing on the ChiNext board. It includes extensive legal review and verification of share capital increases, equity transfers, pricing rationales, and compliance with regulatory procedures. The document references multiple prior legal opinion letters and responses to feedback from the China Securities Regulatory Commission (CSRC). It is not a financial report, earnings release, or management discussion but a legal opinion related to the IPO process. This type of document is best classified as a Regulatory Filing (RNS) because it is a regulatory compliance document and legal opinion related to the IPO, not a financial report or announcement of voting results or capital changes. The document length and content confirm it is not a brief announcement or certification but a substantive legal opinion letter.
2017-06-26 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.